Similarly, improving glycemic control by other insulin sensitizers (302, 408–412), stimulating insulin secretion (413, 414, 416–418), or reducing glucose uptake in the renal tube (419–421) has cardioprotective effects, also restoring myocardial autophagy in DCM models. Here, INS is linked to familial dilated cardiomyopathy.